Requiring health care providers to furnish upon request a list of ingredients contained in an injectable medication that is recommended or administered.
Impact
The introduction of HB 146 could significantly influence state laws concerning patient rights and consumer protection in healthcare. By requiring health care providers to furnish ingredient lists, the bill aims to empower individuals with knowledge about their medications, possibly increasing their trust in medical treatments administered. Additionally, it aligns with a growing demand for transparency in healthcare, particularly within the frameworks of ongoing discussions regarding vaccines and their components.
Summary
House Bill 146 mandates health care providers to provide a list of ingredients for injectable medications upon request. This includes any medications that are administered via injection, such as vaccines. The intention of the bill is to enhance transparency in the pharmaceutical sector by ensuring that patients, or their guardians, have access to critical information regarding what substances are contained in the medicines they are receiving. This is particularly pertinent in the context of public health and safety, as it allows patients to make informed decisions about their treatments.
Contention
While the bill aims to promote transparency, it may face opposition from certain stakeholders who argue that the requirements could place additional burdens on healthcare providers. Concerns may arise around the practical implications for physicians and pharmacists who may need to adjust their processes to accommodate these requests. Furthermore, the bill's exemption for investigational drugs and emergency situations might provoke discussions over the adequacy and safety of such provisions for patients involved in those situations.
Permits students diagnosed with asthma, a condition that may lead to bronchospasm or anaphylaxis, or both, to carry and self-administer asthma medication or auto-injectable or intranasal epinephrine, or both.
Permits students diagnosed with asthma, a condition that may lead to bronchospasm or anaphylaxis, or both, to carry and self-administer asthma medication or auto-injectable or intranasal epinephrine, or both.
Requires that all cosmetics manufactured, sold, delivered, held or offered for sale contain a label that completely and accurately list all of their component ingredients.